top of page

News & Updates

Filter by:

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

News & Updates

Jan 10, 2025

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services

Read More
Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

News & Updates

Jan 2, 2025

Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics

Read More
Lucence Secures MolDX Approval for LiquidHALLMARK® ctDNA and ctRNA Liquid Biopsy Test to Advance Non-Invasive Cancer Diagnostics
Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans

News & Updates

Oct 28, 2024

Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans

Read More
Lucence Announces Expanded Access for LiquidHALLMARK® Liquid Biopsy Test Through Participation Across Regence Plans
Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types

News & Updates

Oct 2, 2024

Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types

Read More
Lucence and Diagnostics Development Hub (DxD Hub) Collaborate on Expanding Multi-Cancer Early Detection Testing to Alternative Sample Types
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting

News & Updates

Jul 4, 2024

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting

Read More
Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2024 ASCO Annual Meeting
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

News & Updates

Feb 26, 2024

Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study

Read More
Lucence Confirms Comprehensive Medicare Coverage for LiquidHALLMARK® and Demonstrates Sensitive Detection of Lung Cancer Biomarkers in Prospective Study
Interim Results from LIQUIK Prospective Study Released at WCLC 2023

News & Updates

Sep 8, 2023

Interim Results from LIQUIK Prospective Study Released at WCLC 2023

Read More
Interim Results from LIQUIK Prospective Study Released at WCLC 2023
Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

News & Updates

Aug 7, 2023

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

Read More
Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®
Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

News & Updates

Jul 24, 2023

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

Read More
Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

1

/

5

bottom of page